PolyPhil™ Next
- Composition: PN-HPT® 20 mg/2 ml; hyaluronic acid 20 mg/2 ml
- Pack Content: 1 syringe x 2 ml
- Needle: 2x 30G x 1/2, 13mm
- Suggested applications: Mature and dehydrated skin – face, middle third, scars, acne scars
- Depth of injection: Intradermal
- Injection technique: Microdroplet, linear or fan technique (needle)
A hybrid injectable of polynucleotides and hyaluronic acid
A hybrid injectable of polynucleotides and hyaluronic acid to both stimulate and hydrate the skin. For dehydrated and mature skins ideal for the face, neck and chest, can also be used for scarring.
Purpose
As a stand-alone therapy, combined formulation determines a synergic action to significantly improve skin hydration in association with fostering fibroblasts resulting in the restauration or/and improvement of the skin elasticity, trophism, firmness, tone and appearance. Remodelling striae distensae and depressed scars, as part of personalised treatment protocols.1
Skin Enhancement Technique (SET) to generates a synergistic effect and helps prepare the skin before other aesthetic procedures: PRP, filler, peeling, needling and surgery.
References:
1 PolyPhil Instruction for use
2 Cavallini M, Papagni M. Long Chain Polynucleotides Gel and Skin Biorevitalization. International Journal of Plastic Dermatology-ISPLAD. 2007; 3(3): 27-32
3 Cavallini M, Bartoletti E, Maioli L, Massirone A, Pia Palmieri I, Papagni M et al. Consensus report on the use of PN-HPT™ (polynucleotides highly purified technology) in aesthetic medicine. J Cosmet Dermatol. 2021 Mar;20(3):922-928. doi: 10.1111/jocd.13679. Epub 2020 Sep 21. PMID: 32799391; PMCID: PMC7984045
Available with CE 0373